Mirae Asset Global Etfs Holdings Ltd. Vanda Pharmaceuticals Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 29,286 shares of VNDA stock, worth $151,994. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,286Holding current value
$151,994% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VNDA
# of Institutions
154Shares Held
45MCall Options Held
132KPut Options Held
220K-
Black Rock Inc. New York, NY8.14MShares$42.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.11MShares$21.4 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$17.8 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.26MShares$11.7 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.15MShares$11.2 Million1.49% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $294M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...